SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief executive officer, Ajay Nirula, M.D., Ph.D., executive vice president and head of research and development, and Brian Hodous, Ph.D., chief scientific officer, will participate in the Stifel 2025 Virtual Immunology and Inflammation Forum. An overview of the company will be presented on Tuesday, ...